Kaiser Permanente Addiction Medicine and Recovery Servs

Kaiser Permanente Addiction Medicine and Recovery Servs

Services:
Special Programs/Groups Offered
• Seniors or older adults
• Clients with co-occurring mental and substance use disorders
• Adolescents
• Lesbian, gay, bisexual, transgender, or queer/questioning (LGBTQ)

Transitional Services

• Discharge Planning
• Naloxone and overdose education
• Aftercare/continuing care

Payment/Insurance/Funding Accepted

• Private health insurance
• Medicare

Hospitals

• General Hospital (including VA hospital)

Education and Counseling Services

• Health education services other than HIV/AIDS or hepatitis
• Family counseling
• Smoking/vaping/tobacco cessation counseling
• Substance use disorder education
• Individual counseling
• Group counseling

Language Services

• Sign language services for the deaf and hard of hearing
• Spanish

Facility Smoking Policy

• Smoking not permitted

Opioid Medications used in Treatment

• Buprenorphine used in Treatment
• Naltrexone used in Treatment

External Opioid Medications Source

• Other contracted prescribing entity

Facility Operation (e.g., Private, Public)

• Private non-profit organization

Ancillary Services

• Case management service
• Social skills development
• Mental health services

Detoxification (medical withdrawal) Services

• Methamphetamines detoxification
• Opioids detoxification
• Benzodiazepines Detoxification
• Alcohol Detoxification
• Medication routinely used during detoxification
• Cocaine Detoxification

Type of Alcohol Use Disorder Treatment

• This facility administers/prescribes medication for alcohol use disorder
• Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere

Gender Accepted

• Male
• Female

Type of Opioid Treatment

• Relapse prevention with naltrexone
• Prescribes naltrexone
• Prescribes buprenorphine
• Accepts clients using MAT but prescribed elsewhere
• Buprenorphine maintenance
• Buprenorphine detoxification
• Lofexidine or Clonidine detoxification
• Maintenance service with medically supervised withdrawal after stabilization

Type of Care

• Substance use treatment
• Detoxification
• Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children

Pharmacotherapies

• Non-nicotine smoking/tobacco cessation
• Naltrexone (extended-release, injectable)
• Buprenorphine with naloxone
• Buprenorphine without naloxone
• Clonidine
• Disulfiram
• Medication for mental disorders
• Naltrexone (oral)
• Nicotine replacement
• Acamprosate (Campral®)

Assessment/Pre-treatment

• Screening for mental disorders
• Screening for substance use
• Screening for tobacco use
• Interim services for clients
• Comprehensive substance use assessment
• Comprehensive mental health assessment

Recovery Support Services

• Self-help groups

License/Certification/Accreditation

• State department of health
• State Substance use treatment agency
• The Joint Commission
• National Committee for Quality Assurance (NCQA)
• Hospital licensing authority

Age Groups Accepted

• Children/Adolescents

Treatment Approaches

• Telemedicine/telehealth therapy
• Trauma-related counseling
• Brief intervention
• Relapse prevention
• Cognitive behavioral therapy
• Substance use disorder counseling
• Motivational interviewing

External Source of Medications Used for Alcohol Use Disorder Treatment

• No formal relationship with prescribing entity

Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)

• Outpatient day treatment or partial hospitalization
• Regular outpatient treatment
• Outpatient detoxification
• Outpatient methadone/buprenorphine or naltrexone treatment
• Intensive outpatient treatment
• Outpatient

Testing

• Drug or alcohol urine screening
• Breathalyzer or blood alcohol testing

Facility Vaping Policy

• Vaping permitted in designated area